By focusing on communities with elevated mortality burdens, the project aimed to identify whether routine azithromycin use ...

Efforts to reduce child mortality in Africa via mass treatment with the antibiotic azithromycin (AZM) may lead to increased ...

Researchers from the University of Liverpool have worked on a UCL-led study that illustrates efforts to reduce child ...

Two new antibiotics offer hope for people with gonorrhoea that is resistant to currently available drugs. Yet, it might be years before the people who need these medicines can get them. Spotlight ...

Gepotidacin was non-inferior to ceftriaxone plus azithromycin for the primary outcome of microbiological success. 2. There were no serious or treatment-related adverse events in either group. Evidence ...

mail.ubc.ca Background Low-dose oral azithromycin therapy is recommended as a preventive treatment for acute exacerbations of COPD. However, the overall benefit–harm balance of this treatment has not ...

Deglycosylated azithromycin (Deg-AZM), a newly developed Class I drug with good therapeutic effects on chronic constipation, has been approved for clinical trials in 2024. However, it is unclear ...

Azithromycin is a water-insoluble drug, with a very low bioavailability. In order to increase the solubility and dissolution rate, and consequently increase the bioavailability of poorly-soluble drugs ...

Please provide your email address to receive an email when new articles are posted on . Azithromycin for 5 days was studied against placebo. Futility analyses stopped this trial early. Being ...

Overall, 3008 N gonorrhoeae isolates from 23 European countries were analysed for their susceptibility to antimicrobials — ceftriaxone, cefixime, azithromycin, and ciprofloxacin. Tests for ...

Subjects received low-dose azithromycin (n=55) or placebo (n=54) as add-on treatment to combination therapy of inhaled corticosteroids and long-acting β 2 agonists for 6 months. The primary outcome ...